AUM Biosciences is focused on advancing a clinical pipeline of precision oncology therapeutics designed to deploy multi-faceted inhibition strategies to reverse cancer resistance

Hitting the wall of cancer resistance

When cancer cells are threatened, their mutation rate increases, resulting in the evolvement of ways to evade the immune system and become resistant to anti-cancer therapies that were previously effective